Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

  2022 2021 2020 2019 2018

Year wise published articles

30 30 13 4 7

Year wise citations received

59 69 60 48 62
Journal total citations count 548
Journal Impact Factor 2.31
Journal 5 years Impact Factor 3.74
Journal CiteScore 4.86
Journal h-index 12
Important citations

Bowman CE. Individualised divergences. Geometry Driven Statistics. 2015 Sep 3;121:337.

Mitteroecker P, Cheverud JM, Pavlicev M. Multivariate analysis of genotype–phenotype association. Genetics. 2016 Apr 1;202(4):1345-63.

Yamamoto J, Ohnuma K, Hatano R, Okamoto T, Komiya E, Yamazaki H, Iwata S, Dang NH, Aoe K, Kishimoto T, Yamada T. Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma. British journal of cancer. 2014 Apr 29;110(9):2232-45.

Prediction of synthetic lethal relationship by literature survey: case study of colorectal cancer

Sultana S. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences.

Eltyeb S, Salim N. Chemical named entities recognition: a review on approaches and applications. Journal of cheminformatics. 2014 Apr 28;6(1):17.

Kang Q, Parkin B, Giraldez MD, Tewari M (2016) Mutant DNA quantification by digital PCR can be confounded by heating during DNA fragmentation. BioTechniques 60: 175.

Wang H, Fang J, Liang C, He M, Li Q (2011) Competing interests. BioTechniques 51: 421-423.

Sultana S (2016) Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences.

Bielinski SJ, St Sauver JL, Olson JE, Wieland ML, Vitek CR, et.al (2016) Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?. The Pharmacogenomics Journal

Brito M (2015) A farmacogenética e a medicina personalizada. Saúde & Tecnologia. 2015:5-10.

Getachew A (2015) Molecular characterization of Glucose-6-Phosphate Dehydrogenase deficiency specific variants among selected populations in malaria endemic areas of Ethiopia (Doctoral dissertation, AAU).

Ivanov DD, Melnik OO (2016) Pharmacogenetic Tests in the Nephrological Clinic. KIDNEYS 4.18: 12-6.

Иванов ДД, Мельник АА (2016) Фармакогенетическое тестирование в нефрологической клинике. Почки. 2016: 12-16.

Иванов ДД, Мельник АА (2016) Фармакогенетическое тестирование в нефрологической клинике. Почки 2016: 12-16.

Леонова МВ (2016) Фармакогенетика артериальной гипертонии: особенности фармакогенетики торасемида. Фармакогенетика и фармакогеномика 1.

Iffland K, Grotenhermen F (2016) Safety and Side Effects of Cannabidiol–A review of clinical data and relevant animal studies.

Sultana S (2015) Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences.

Giese C (2015) Biocatalytic oxidation reactions for sustainable syntheses of bulk and fine chemicals.

Hill FJ, McCloskey SJ, Sheerin N (2015) From a fish tank injury to hospital haemodialysis: the serious consequences of drug interactions. BMJ case reports 2015: bcr2015209961.